Intra-abdominal rhizopus microsporus infection successfully treated by combined aggressive surgical, antifungal, and iron chelating therapy

Journal of Pediatric Hematology/Oncology

Volumn 32, Issue 6, 2010, Pages e238-e240

  Ting, Joseph Yuk ^a   Chan, Shu Yan ^a   Lung, David Christopher ^b   Ho, Alvin Chi Chung ^a   Chiang, Alan Kwok Shing ^a   Ha, Shau Yin ^a   Tsoi, Nelson Nai Shun ^a   Chan, Godfrey Chi Fung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b TUEN MUN HOSPITAL   (Hong Kong)

Author keywords

Iron chelator; Rhizopus; Zygomycosis

Indexed keywords

ALLOPURINOL; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ASPARAGINASE; CASPOFUNGIN; CYTARABINE; DAUNORUBICIN; DEFERASIROX; DEXAMETHASONE; ETOPOSIDE; GRANULOCYTE COLONY STIMULATING FACTOR; HEMOGLOBIN; IDARUBICIN; METHOTREXATE; MITOXANTRONE; POSACONAZOLE; PREDNISOLONE; TIOGUANINE; VINCRISTINE; VORICONAZOLE; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; IRON CHELATING AGENT;

ABDOMINAL INFECTION; ABDOMINAL PAIN; ABDOMINAL RADIOGRAPHY; ABDOMINAL TENDERNESS; ACUTE LYMPHOBLASTIC LEUKEMIA; APPENDECTOMY; APPENDICITIS; ARTICLE; ARTIFICIAL VENTILATION; B CELL LEUKEMIA; BACTEROIDES; BONE MARROW TRANSPLANTATION; CASE REPORT; CHILD; COLITIS; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DOPPLER FLOWMETRY; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ERYTHEMA; FEBRILE NEUTROPENIA; FEVER; FUNGAL CONTAMINATION; FUNGUS CULTURE; GRAFT VERSUS HOST REACTION; HEMODYNAMICS; HEMOGLOBIN BLOOD LEVEL; HEMOPERITONEUM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFERIOR CAVA VEIN; IRON CHELATION; KARYOTYPING; KIDNEY INFARCTION; KLEBSIELLA PNEUMONIAE; LAPAROTOMY; LEUKOCYTE COUNT; MALE; MICROSCOPY; MUCORMYCOSIS; NEUTROPHIL COUNT; PERITONITIS; PNEUMOPERITONEUM; POSTOPERATIVE CARE; PRIORITY JOURNAL; PSOAS MUSCLE; REAL TIME POLYMERASE CHAIN REACTION; RETROPERITONEAL DISEASE; RHIZOPUS; RHIZOPUS MICROSPORUS; SHOCK; SURVIVAL; TABLET; THROMBOCYTE COUNT; TISSUE NECROSIS; TREATMENT DURATION; VEIN THROMBOSIS; ZYGOMYCOSIS; ABDOMEN; ACUTE GRANULOCYTIC LEUKEMIA; CHEMICALLY INDUCED DISORDER; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; MICROBIOLOGY; MULTIMODALITY CANCER THERAPY; NEUTROPENIA; PATHOPHYSIOLOGY;

ABDOMEN; ANTIFUNGAL AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; COMBINED MODALITY THERAPY; HUMANS; IMMUNOCOMPROMISED HOST; IRON CHELATING AGENTS; LEUKEMIA, MYELOID, ACUTE; MALE; MUCORMYCOSIS; NEUTROPENIA; PRECURSOR B-CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RHIZOPUS;

EID: 77955916824     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0b013e3181e622bf     Document Type: Article

References (20)

1. Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev. 2000; 13: 236-301.
2. Zaoutis TE, Roilides E, Chiou CC, et al. Zygomycosis in children: a systematic review and analysis of reported cases. Pediatr Infect Dis J. 2007; 26: 723-727.
3. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis. 2005; 41: 634-653.
4. Van Well GT, Van Groeningen I, Debets-Ossenkopp YJ, et al. Zygomycete infection following voriconazole prophylaxis. Lancet Infect Dis. 2005; 5: 594.
5. Alvarez E, Sutton DA, Cano J, et al. Spectrum of zygomycete species identified from clinically significant specimens in the United States. J Clin Microbiol. 2009; 47: 1650-1656.
6. Monecke S, Hochauf K, Gottschlich B, et al. A case of peritonitis caused by Rhizopus microsporus. Mycoses. 2006; 49: 139-142.
7. De Mol P, Meis JF. Disseminated Rhizopus microsporus infection in a patient on oral corticosteroid treatment: a case report. Neth J Med. 2009; 67: 25-28.
8. Sedlacek P, Vavra V, Masova I, et al. Successful therapy with ABLC, surgery and posaconazole for Rhizopus microsporus var. rhizopodiformis liver eumycetoma in a child with acute leukaemia. Mycoses. 2009; 52: 276-279.
9. Stark D, Milliken S, Marriott D, et al. Rhizopus microsporus var. rhizopodiformis sinus-orbital zygomycosis in an immunosuppressed patient: successful treatment with posaconazole after a complicated clinical course. J Med Microbiol. 2007; 56(Pt 5): 699-701.
10. Mitchell SJ, Gray J, Morgan ME, et al. Nosocomial infection with Rhizopus microsporus in preterm infants: association with wooden tongue depressors. Lancet. 1996; 348: 441-443.
11. Maravi-Poma E, Rodriguez-Tudela JL, de Jalon JG, et al. Outbreak of gastric mucormycosis associated with the use of wooden tongue depressors in critically ill patients. Intensive Care Med. 2004; 30: 724-728.
12. Cheng VC, Chan JF, Ngan AH, et al. Outbreak of intestinal infection due to Rhizopus microsporus. J Clin Microbiol. 2009; 47: 2834-2843.
13. Greenberg RN, Mullane K, van Burik JA, et al. Posaconazole as salvage therapy for zygomycosis. Antimicrob Agents Chemother. 2006; 50: 126-133.
14. Reed C, Bryant R, Ibrahim AS, et al. Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis. Clin Infect Dis. 2008; 47: 364-371.
15. Boelaert JR, Van Cutsem J, de Locht M, et al. Deferoxamine augments growth and pathogenicity of Rhizopus, while hydroxypyridinone chelators have no effect. Kidney Int. 1994; 45: 667-671.
16. Ibrahim AS, Spellberg B, Edwards J. Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment. Curr Opin Infect Dis. 2008; 21: 620-625.
17. Chan GC, Chan S, Ho PL, et al. Effects of chelators (deferoxamine, deferiprone and deferasirox) on the growth of Klebsiella pneumoniae and Aeromonas hydrophila isolated from transfusion-dependent thalassemia patients. Hemoglobin. 2009; 33: 352-360.
18. Ibrahim AS, Edwards JE, Fu Y, et al. Deferiprone iron chelation as a novel therapy for experimental mucormycosis. J Antimicrob Chemother. 2006; 58: 1070-1073.
19. Ibrahim AS, Gebermariam T, Fu Y, et al. The iron chelator deferasirox protects mice from mucormycosis through iron starvation. J Clin Invest. 2007; 117: 2649-2657.
20. Reed C, Ibrahim A, Edwards JE, et al. Deferasirox, an iron-chelating agent, as salvage therapy for rhinocerebral mucormycosis. Antimicrob Agents Chemother. 2006; 50: 3968-3969.